Can a special shake help cervical cancer patients tolerate chemo better?
NCT ID NCT06349148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special nutritional drink (immunonutrition) can help malnourished cervical cancer patients better tolerate chemotherapy and improve their quality of life. Fifty patients receiving standard chemoradiation will be randomly assigned to get either the special drink or a standard nutritional drink. The main goal is to see if the special drink reduces severe side effects that force treatment delays or dose reductions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
immunonutrition drink (Impact, Nestlé)
What this could lead to
If it works, this could help cervical cancer patients complete their chemotherapy with fewer side effects and better nutrition.
What could go wrong
This is a small early-stage study with only 50 participants, so results may not apply to everyone. The special drink is expensive and may not be widely available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, 100021, China
Contact